Skip to main content
. 2020 Nov 1;202(9):1253–1261. doi: 10.1164/rccm.201911-2172OC

Table 2.

Outcomes and Renin Concentration

  Patients below the Study Population Median Renin [Median (IQR)]
P Value Patients above the Study Population Median Renin [Median (IQR)]
P Value
Treatment with Placebo (n = 63) Treatment with Angiotensin II (n = 64) Treatment with Placebo (n = 73) Treatment with Angiotensin II (n = 55)
28-d mortality, % 44 (33–58) 45 (34–58) 0.70 70 (59–80) 51 (39–65) 0.01
Ventilator liberation by Day 7 (alive and vent-free), % 38 (27–52) 27 (18–40) 0.20 14 (8–25) 28 (18–43) 0.07
RRT liberation by Day 7 (alive and RRT free), % 14 (4–46) 28 (13–54) 0.33 12 (5–27) 43 (25–66) 0.01
ICU discharge by Day 28, % 52 (41–65) 39 (28–52) 0.13 22 (14–33) 44 (32–58) 0.02

Definition of abbreviations: IQR = interquartile range; RRT = renal replacement therapy.